Liu, K H <br/><br/>
Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes.  [electronic resource] 

 -  Xenobiotica; the fate of foreign compounds in biological systems  May 2004 
 - 429-38 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-8254 
<br/><br/><label>Standard No.: </label>10.1080/00498250410001691253  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Chromones--pharmacology<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Hydroxylation<br/>In Vitro Techniques<br/>Indoles<br/>Kinetics<br/>Leukotriene Antagonists--pharmacology<br/>Microsomes, Liver--drug effects<br/>Phenylcarbamates<br/>Sulfonamides<br/>Tolbutamide--metabolism<br/>Tosyl Compounds--pharmacology